Symptoms of Transient Ischemic Attacks

ByABC News
February 25, 2002, 10:55 AM

— -- A TIA (Transient Ischemic Attacks) is an important warning sign that can happen before a major stroke occurs. The symptoms of TIA are similar to a stroke, but resolve quickly. Symptoms of TIA can include the following sudden symptoms:

· Weakness in an arm, hand or leg· Numbness on one side of the body· Loss or blurring of vision in one or both eyes· Difficulty talking or understanding speech· Imbalance, loss of coordination

By current definition, TIA symptoms resolve within 24 hours, but most last less than 90 minutes and they frequently reverse over several minutes. Because the symptoms go away, many persons dismiss the spell with potentially dangerous consequences.

Even health professionals need to be more aware of the significance of TIAs as one study found that one-third of TIA patients had no specific evaluations over the first month, the period of greatest risk.

A recent study showed that one in ten patients having a TIA went on to have a stroke over the next 3 months with over half occurring over the first two days. A lot can be done to prevent stroke in persons who have had a TIA, provided that they rapidly seek appropriate medical care.

· Some TIAs are related to narrowing of the large arteries in the neck (carotid arteries). Several well-done clinical trials show that an operation to remove the narrowing (carotid endarterectomy) significantly decreases the risk of stroke when done in appropriately selected patients by skilled surgeons. Studies are in progress testing the use of a balloon to widen the area of narrowing and the placement of a tube to keep the artery open (called a stent).

· Some TIAs or minor strokes can be associated with atrial fibrillation (an irregular beating of the upper chamber of the heart that can lead to blood clots to form). Several studies show that selected patients with atrial fibrillation benefit from treatment with a blood thinner (the anticoagulant warfarin). However, studies show that this is used in only about half of patients who might qualify to receive the drug.